Johnson & Johnson’s Single-Dose Coronavirus Vaccine Enters Late-Stage Trials

Pharmaceutical titan Johnson & Johnson said 60,000 people will be enrolled for its phase three trial of its single-dose coronavirus vaccine, the company said Wednesday, becoming the fourth shot as part of the Trump administration’s Operation Warp Speed to enter late-stage testing in the U.S.